Biotage AB (Biotage AB) EV-to-EBIT : 38.53 (As of May. 01, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Biotage AB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Biotage AB's Enterprise Value is $1,200.9 Mil. Biotage AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $31.2 Mil. Therefore, Biotage AB's EV-to-EBIT for today is 38.53.

The historical rank and industry rank for Biotage AB's EV-to-EBIT or its related term are showing as below:

BITGF' s EV-to-EBIT Range Over the Past 10 Years
Min: 10.14 Med: 34.23 Max: 63.43
Current: 40.02

During the past 13 years, the highest EV-to-EBIT of Biotage AB was 63.43. The lowest was 10.14. And the median was 34.23.

BITGF's EV-to-EBIT is ranked worse than
77.37% of 464 companies
in the Medical Devices & Instruments industry
Industry Median: 20.305 vs BITGF: 40.02

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Biotage AB's Enterprise Value for the quarter that ended in Mar. 2024 was $1,322.6 Mil. Biotage AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $31.2 Mil. Biotage AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 2.36%.

Biotage AB EV-to-EBIT Historical Data

The historical data trend for Biotage AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB EV-to-EBIT Chart

Biotage AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

37.87

39.18

63.16

34.04

32.79

Biotage AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															27.30	39.33	35.56	32.79	43.51

Competitive Comparison of Biotage AB's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Biotage AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotage AB's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Biotage AB's EV-to-EBIT falls into.

Biotage AB EV-to-EBIT Calculation

Biotage AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	1200.945	/	31.166
	=	38.53

Biotage AB's current Enterprise Value is $1,200.9 Mil.
Biotage AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $31.2 Mil.

Biotage AB (OTCPK:BITGF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Biotage AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	31.166	/	1322.556334
	=	2.36 %

Biotage AB's Enterprise Value for the quarter that ended in Mar. 2024 was $1,322.6 Mil.
Biotage AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $31.2 Mil.

Biotage AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Biotage AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotage AB (Biotage AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

BIOT:Sweden 0GRP:UK PQX1:Germany

Address

Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03

Website

https://www.biotage.com

Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.